News & Updates

Show Multimedia Only
Long-term oral progestogen therapy effective, well tolerated in endometriosis management
Long-term oral progestogen therapy effective, well tolerated in endometriosis management
19 Mar 2025 byDr. Tak-Keung Sum, Specialist in Obstetrics and Gynaecology, Private practice, Hong Kong

Endometriosis is a chronic disease, which requires interventions that are both effective and well tolerated in the long term. Dr Tak-Keung Sum, Specialist in Obstetrics and Gynaecology in private practice in Hong Kong, reviews clinical and real-world evidence on the long-term efficacy and safety of an oral progestogen, dienogest (Visanne®, Bayer), and shares his personal experience in managing endometriosis across different patient profiles.

Long-term oral progestogen therapy effective, well tolerated in endometriosis management
19 Mar 2025
HF care puts a dent on SG’s healthcare system
HF care puts a dent on SG’s healthcare system
18 Mar 2025 byAudrey Abella

A study evaluating the annual healthcare burden of heart failure with reduced ejection fraction (HFrEF; EF <40 percent) in Singapore shows that hospital-based HF care has a significant financial impact on Singapore’s healthcare system.

HF care puts a dent on SG’s healthcare system
18 Mar 2025